dosedrugsOnlineOfflineع
You're offline — running on data saved to your device.

Ribociclib: prices and alternatives

Indicated in combination with endocrine therapy for HR-positive, HER2-negative early, advanced, or metastatic breast cancer in appropriate patients.

2 products with this active ingredient from 1 manufacturer. Official prices from 24482 to 69366 EGP.

Every box with this active ingredient, cheapest first.

Kisqali 200 mg 21 f.c. tabsKisqali 200 mg 21 f.c. tabsكيسكالي 200 مجم 21 قرصribociclib · NovartisOfficial public price24482EGP
Kisqali 200 mg 63 f.c. tabsKisqali 200 mg 63 f.c. tabsكيسكالي 200 مجم 63 قرصribociclib · NovartisOfficial public price69366EGP

Informational only — may be inaccurate or incomplete. Don't rely on it medically; verify with a pharmacist.